Logo image
Broad-Spectrum Anti-Human Immunodeficiency Virus (HIV) Potential of a Peptide HIV Type 1 Entry Inhibitor
Journal article   Open access   Peer reviewed

Broad-Spectrum Anti-Human Immunodeficiency Virus (HIV) Potential of a Peptide HIV Type 1 Entry Inhibitor

Simon Cocklin, Hosahudya Gopi, Bianca Querido, Manideepthi Nimmagadda, Syna Kuriakose, Claudia Cicala, Sandya Ajith, Sabine Baxter, James Arthos, Julio Martín-García, …
Journal of virology, v 81(7), pp 3645-3648
Apr 2007
PMID: 17251295
url
https://doi.org/10.1128/JVI.01778-06View
Published, Version of Record (VoR) Open

Abstract

Vaccines and Antiviral Agents
The AIDS epidemic continues to spread at an alarming rate worldwide, especially in developing countries. One approach to solving this problem is the generation of anti-human immunodeficiency virus (HIV) compounds with inhibition spectra broad enough to include globally prevailing forms of the virus. We have examined the HIV type 1 (HIV-1) envelope specificity of a recently identified entry inhibitor candidate, HNG-105, using surface plasmon resonance spectroscopy and pseudovirus inhibition assays. The combined results suggest that the HNG-105 molecule may be effective across the HIV-1 subtypes, and they highlight its potential as a lead for developing therapeutic and microbicidal agents to help combat the spread of AIDS.

Metrics

1 Record Views
41 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Virology
Logo image